Castle Biosciences (CSTL) Total Non-Current Liabilities (2018 - 2026)
Castle Biosciences' (CSTL) quarterly Total Non-Current Liabilities came in at $91.1 million in Q2 2026, up 4.94% year-over-year from $86.9 million in Q2 2025, and up 7.37% quarter-over-quarter from $84.9 million in Q1 2026.
Powered by 
Analysis
Castle Biosciences (CSTL) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Castle Biosciences has disclosed Total Non-Current Liabilities across 9 years of filings, most recently posting $91.1 million for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities rose 4.94% year-over-year to $91.1 million; the TTM figure through Jun 2026 stood at $91.1 million (up 4.94% YoY), while the FY2025 annual figure was $106.2 million, up 40.83% from the prior year.
- Total Non-Current Liabilities came in at $91.1 million for Q2 2026 at Castle Biosciences, up from $84.9 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $106.2 million in Q4 2025 to a low of $34.8 million in Q2 2022.
- Average Total Non-Current Liabilities over 5 years is $65.0 million, with a median of $62.1 million recorded in 2023.
- Year-over-year, Total Non-Current Liabilities jumped 151.53% in 2022 and slipped 11.28% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $48.1 million in 2022, then climbed by 29.08% to $62.1 million in 2023, then increased by 21.47% to $75.4 million in 2024, then surged by 40.83% to $106.2 million in 2025, then slipped by 14.16% to $91.1 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $91.1 million in Q2 2026, $84.9 million in Q1 2026, and $106.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 715.49 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 8.06 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 9.19 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 2.01 Bn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 1.86 Bn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 584.41 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 2.59 Bn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 490.00 Mn |
| 10 | Castle Biosciences | 1.08 Bn | 811.36 Mn | 79.85 Mn | 91.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91.15 Mn |
| Mar 31, 2026 | 84.89 Mn |
| Dec 31, 2025 | 106.18 Mn |
| Sep 30, 2025 | 93.24 Mn |
| Jun 30, 2025 | 86.85 Mn |
| Dec 31, 2024 | 75.40 Mn |
| Sep 30, 2024 | 73.51 Mn |
| Jun 30, 2024 | 63.42 Mn |
| Mar 31, 2024 | 56.03 Mn |
| Dec 31, 2023 | 62.07 Mn |
| Sep 30, 2023 | 50.20 Mn |
| Jun 30, 2023 | 46.59 Mn |
| Mar 31, 2023 | 41.69 Mn |
| Dec 31, 2022 | 48.09 Mn |
| Sep 30, 2022 | 44.58 Mn |
| Jun 30, 2022 | 34.77 Mn |
| Mar 31, 2022 | 46.99 Mn |
| Dec 31, 2021 | 32.55 Mn |
| Sep 30, 2021 | 21.98 Mn |
| Jun 30, 2021 | 19.49 Mn |
API Access
Castle Biosciences Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CSTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "CSTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CSTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();